Intimacy, Condom Use, and Pre-Exposure Prophylaxis (PrEP) Acceptability among Men Who Have Sex with Men (MSM) in Primary Partnerships: A Comment on Gamarel and Golub

Annals of Behavioral Medicine

Volumn 49, Issue 2, 2015, Pages 151-153

  Underhill, Kristen ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

BEHAVIOR; HIV INFECTIONS; HUMAN; MALE; MOTIVATION; PRE-EXPOSURE PROPHYLAXIS; SEXUAL BEHAVIOR;

ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; INTENTION; MALE; MOTIVATION; PRE-EXPOSURE PROPHYLAXIS; SEXUAL BEHAVIOR;

EID: 84925532779     PISSN: 08836612     EISSN: 15324796     Source Type: Journal    
DOI: 10.1007/s12160-014-9651-6     Document Type: Editorial

References (38)

1. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-2599.
2. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399-410.
3. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423-434.
4. Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381:2083-2090.
5. Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012, 4:151ra125.
6. Donnell D, Baeten JM, Bumpus NN, et al. HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention. J Acquir Immune Defic Syndr. 2014.
7. Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18:195-216.
8. Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11:e1001613.
9. Bush S, Rawlings K, Ng L, Mera R. Regional differences in the utilization of Truvada for PrEP. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 353.
10. Mera R, Rawlings K, Pechonkina A, et al. Status of Truvada (TVD) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States: An Early Drug Utilization Analysis. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, CO, 2013, Abstract H-663a.
11. Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014.
12. Ndase P, Celum C, Campbell J, et al. Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the Partners PrEP study experience. J Acquir Immune Defic Syndr. 2014;66:206-212.
13. King HL, Keller SB, Giancola MA, et al. Pre-Exposure Prophylaxis Accessibility Research and Evaluation (PrEPARE Study). AIDS Behav. 2014;18:1722-1725.
14. Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11:166-170.
15. CDC: HIV among gay and bisexual men. Atlanta, GA: U.S. Dept of Health and Human Services, 2014.
16. Mimiaga MJ, Closson EF, Kothary V, Mitty JA. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Arch Sex Behav. 2014;43:99-106.
17. Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012;7:e50061.
18. Brooks RA, Kaplan RL, Lieber E, et al. Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care. 2011;23:1136-1145.
19. Brooks RA, Landovitz RJ, Kaplan RL, et al. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDS. 2012;26:87-94.
20. Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One. 2012;7:e50522.
21. Sullivan PS, Salazar L, Buchbinder S, Sanchez TH. Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS. 2009;23:1153-1162.
22. Burton J, Darbes L, Operario D. Couples-focused behavioral interventions for prevention of HIV: Systematic review of the state of the evidence. AIDS Behav. 2010;14:1-10.
23. Karney BR, Hops H, Redding CA, et al. A framework for incorporating dyads in models of HIV-prevention. AIDS Behav. 2010;14:189-203.
24. Hoff CC, Chakravarty D, Beougher SC, Neilands TB, Darbes LA. Relationship characteristics associated with sexual risk behavior among MSM in committed relationships. AIDS Patient Care STDs. 2012;26:738-745.
25. Darbes LA, Chakravarty D, Neilands TB, Beougher SC, Hoff CC. Sexual risk for HIV among gay male couples: a longitudinal study of the impact of relationship dynamics. Arch Sex Behav. 2014;43:47-60.
26. Greene GJ, Andrews R, Kuper L, Mustanski B. Intimacy, monogamy, and condom problems drive unprotected sex among young men in serious relationships with other men: a mixed methods dyadic study. Arch Sex Behav. 2014;43:73-87.
27. Golub SA, Starks TJ, Payton G, Parsons JT. The critical role of intimacy in the sexual risk behaviors of gay and bisexual men. AIDS Behav. 2012;16:626-632.
28. Gamarel KE, Golub SA: Intimacy Motivations and Pre-exposure Prophylaxis (PrEP) Adoption Intentions Among HIV-Negative Men Who Have Sex with Men (MSM) in Romantic Relationships. Ann Behav Med. 2014. doi:10.1007/s12160-014-9646-3.
29. Gilmore H, Koester K, Liu A, et al. To take or not to take PrEP: Perspectives from participants enrolled in the iPrEx Open Label Extension (OLE) in the United States. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 440.
30. Koester K, Amico KR, Liu A, et al. Sex on PrEP: qualitative findings from the iPrEx open label extension (OLE) in the US. XX International AIDS Conference. Melbourne, Australia, 2014, Abstract TUAC0102.
31. Patel V, Estabrook S, Smith K, Golub S, et al. Motivators and concerns for adopting pre-exposure prophylaxis in men who have sex with men using mobile dating "apps" in New York City. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 434.
32. Underhill K, Morrow K, Operario D, et al. Project PrEP Talk: An in-depth qualitative analysis of PrEP acceptability, expectations and risk compensation beliefs among United States MSM. XIX International AIDS Conference. Washington, D.C., USA, 2012, Abstract TUPD0306.
33. Corneli A, Perry B, Kawango Agot, et al. Participant Explanations for Study Product Adherence in FEM-PrEP. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 366.
34. Jiwatram-Negron T, El-Bassel N: Systematic Review of Couple-Based HIV Intervention and Prevention Studies: Advantages, Gaps, and Future Directions. AIDS Behav. 2014.
35. Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807-814.
36. Wu E, El-Bassel N, McVinney LD, et al. Feasibility and promise of a couple-based HIV/STI preventive intervention for methamphetamine-using, black men who have sex with men. AIDS Behav. 2011;15:1745-1754.
37. Stephenson R, Sullivan PS, Salazar LF, et al. Attitudes towards couples-based HIV testing among MSM in three US cities. AIDS Behav. 2011;15(Suppl 1):S80-S87.
38. CDC: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States 2014: A Clinical Practice Guideline, 2014.